Suchergebnisse - "KANG DI"

PubPharm (286)

1

Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors

enthalten in: Journal of medicinal chemistry | 2024

von Wang, J. | Rong, Q. | Ye, L. | +10

2

SHP2 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von MA CUNBO | GAO PANLIANG | HU SHAOJING | +4

3

Novel heterocyclic derivatives useful as SHP2 inhibitors

enthalten in: Europäisches Patentamt | 2024

von MA CUNBO | GAO PANLIANG | HU SHAOJING | +4

4

SOLID FORMS OF COMPOUND I OR SALTS THEREOF

enthalten in: Europäisches Patentamt | 2024

von LI HAIJUN | CHEN MINGMING | KANG DI | +4

5

Novel heterocyclic derivatives useful as SHP2 inhibitors

enthalten in: Europäisches Patentamt | 2024

von MA CUNBO | GAO PANLIANG | HU SHAOJING | +4

6

SOLID FORMS OF COMPOUND I OR SALTS THEREOF

enthalten in: Europäisches Patentamt | 2024

von LI HAIJUN | CHEN MINGMING | KANG DI | +4

7

Use of compound in prevention and/or treatment of pathogen infection in animals

enthalten in: Europäisches Patentamt | 2024

von KANG DI | LI DANNI | LIN XINGYU | +1

8

Use of compound in prevention and/or treatment of pathogen infection in animals

enthalten in: Europäisches Patentamt | 2024

von KANG DI | LI DANNI | LIN XINGYU | +1

9

Pathogen infection induces sickness behaviors by recruiting neuromodulatory systems linked to stress and satiety inC. elegans

enthalten in: bioRxiv.org | 2024

von Pradhan, S. | Madan, G. | Kang, D. | +9

10

NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von MA CUNBO | GAO PANLIANG | HU SHAOJING | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]